Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 75.72 Billion | USD 110.61 Billion | 4.3% | 2024 |
FrequentlyAsked Questions
The global pain management therapeutics market is expected to grow due to rising prevalence of chronic pain conditions, advancements in pain relief therapies, increasing demand for personalized medicine, and the growing focus on non-opioid treatment options to address the opioid crisis.
According to a study, the global pain management therapeutics market size was worth around USD 75.72 Billion in 2024 and is expected to reach USD 110.61 Billion by 2034.
The global pain management therapeutics market is expected to grow at a CAGR of 4.3% during the forecast period.
North America is expected to dominate the pain management therapeutics market over the forecast period.
Leading players in the global pain management therapeutics market include GlaxoSmithKline Plc., Novartis AG, Abbott Laboratories, Eli Lilly & Company, Endo Health Solutions Inc., Pfizer Inc., Purdue Pharma L.P., Merck & Co. Inc., Mylan NV., Johnson & Johnson, among others.
The report explores crucial aspects of the pain management therapeutics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed